The Need for Continuous Requalification and Support of Cell and Gene Therapy Distribution
Tuesday, March 19, 2024 at 9:10 AM to 9:30 AM · 20 min. (Europe/London)
Keynote [Track 1]
Presentation
Information
In light of the recent FDA disclosure of contamination risks associated with cell therapy manufacturing, the industry needs to revisit the need for continuous requalification of both the performance of equipment and processes as well as the transportation and distribution.